| Net Cash Provided by (Used in) Operating Activities |
$240,343 |
USD |
-1792% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$169,352 |
USD |
1216% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
137,829,465 |
shares |
4.5% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$91,995 |
USD |
5092% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Valuation Allowance |
$864,887 |
USD |
38% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$864,887 |
USD |
38% |
Q1 2025 |
FY 2025 |
| Depreciation |
$1,500 |
USD |
|
Q2 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,100,861 |
USD |
51% |
Q2 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
$1,500 |
USD |
|
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$4,118,510 |
USD |
38% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
11,300,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Additional Paid in Capital |
$2,593,976 |
USD |
20% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Outstanding |
11,300,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Depreciation, Depletion and Amortization |
$6,518 |
USD |
-67% |
Q2 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |